The professor's research would also benefit the company's existing 3D printed kidney proximal tubule tissue, which will be released as a commercial product next year. Relying on the technology licensed from UniQuest, the company would be able to release a complete kidney tissue product, significantly expanding on their own product. Organovo has been granted worldwide development and commercialization rights for in vitro applications of UQ's technology, with UniQuest receiving an upfront technology access fee and the ability to receive milestone and royalty payments. Image via Nature. Caption: Kidney organoids contain differentiating nephrons, stroma and vasculature with progressive maturation with time in culture.